Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

FUnctional Selection of Advanced Breast Cancer Patients for Talazoparib Treatment Using the REpair Capacity (RECAP) Test: The FUTURE Trial

NCT06193525 is registered in ClinicalTrials.gov with Erasmus Medical Center as lead sponsor.

NCT NCT06193525
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06193525 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
FUnctional Selection of Advanced Breast Cancer Patients for Talazoparib Treatment Using the REpair Capacity (RECAP) Test: The FUTURE Trial
Lead sponsor
Erasmus Medical Center
Phase
Phase 2
Overall status
Recruiting
Start date
September 16, 2019
Completion date
December 31, 2025
Enrollment
66 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

advanced breast cancer